JNJ
HealthcareJohnson & Johnson
Drug Manufacturers - General
$228.44-0.61%
Key events (≥5% daily moves)
Up dayDown day
About This Company
Johnson & Johnson (JNJ) is a global healthcare company that recently streamlined its business. It spun off its well-known consumer brands, like Tylenol and Band-Aid, into a separate company called Kenvue. JNJ now focuses on two core areas: developing innovative prescription medicines for serious diseases and creating advanced medical technologies and devices used by healthcare professionals worldwide. This strategic shift allows JNJ to concentrate on high-growth, innovation-driven segments within the healthcare industry.
https://www.jnj.comKey Statistics
Open$229.06
Day High$229.77
Day Low$227.02
Prev. Close$229.85
52-Week High—
52-Week Low—
Market Cap$549.91B
Volume2.36M
Avg. Volume—
P/E Ratio—
EPS—
Beta0.33
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
138,100
Country
US
IPO Date
1943-01-02
Exchange
NYSE
52-Week Range
—
52W Low
$228.44
Current
—
52W High
Catalysts & Risks
Catalysts
- ▲Robust and diversified product pipeline, particularly in pharmaceuticals and MedTech, driving future revenue growth.
- ▲Strategic acquisitions and partnerships enhancing market share and technological capabilities in key therapeutic areas.
- ▲Consistent dividend growth and share repurchase programs, returning value to shareholders and signaling financial strength.
- ▲Global healthcare demand driven by aging populations and emerging markets, providing a stable and growing market for JNJ's products.
Risks
- ▼Intensifying generic and biosimilar competition impacting pharmaceutical revenue and patent expirations on key drugs.
- ▼Increased regulatory scrutiny and potential for product liability lawsuits, particularly in the pharmaceutical and MedTech segments.
- ▼Fluctuations in foreign exchange rates, given JNJ's significant international presence, affecting reported earnings.
- ▼Healthcare policy changes and pricing pressures from governments and payers, potentially limiting revenue growth and profitability.
AI-generated · For informational use only